发表于 2008-10-09 19:47 IP属地:未知
参考文献
1)Khandwala HM et al. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr. Rev. 21:215-44. 2000.
2)Jerome L. et al. Deregulation of the IGF axis in cancer: epidemiol. Evidence and potential therapeutic intervention. Endocr. Relat. Cancer. 10:561-78. 2003.
3)Yu H. et al. Joint effect of insulin-like growth factors and sex steroids on breast cancer risk. Cancer Epidemiol. Biomarkers and Prev. 12:1067-73.2003.
4)Chan JM, Stampfer MJ, Giovannucci E. et al. Plasma insulin-like growth factor-1 and prostate cancer risk: A prospective study. Science 279:563-6. 1998.
5)Chan JM, Stampfer MJ, et al. Insulin-like growth factor-1 and Insulin-like growth factor binding protein-3 as predicators of advanced-stage prostate cancer. J. Natl. Cancer Inst. 94:1099-1106. 2002
6)Shi R., Berkel HJ, Yu H. Insulin-like growth factor-1 and prostate cancer: a meta-analysis. Br. J. Cancer. 85:991-6. 2001.
7) Oliver SE et al. Screen-detected prostate cancer and the Insulin-like growth factor axis: results of a population-based case-control study. Int. J. Cancer 108:887-92. 2004.
8)Chokkalingam AP et al. Insulin-like growth factors and prostate Cancer: a population-based case-control study in China. Cancer Epidemiol. Biomarkers and Prev. 10:421-7. 2001.
9)Voskuil DW et al. The insulin-like growth factor system in cancer prevention: potential of dietary intervention strategies. Cancer Epidemiol. Biomarkers and Prev. 14 (1):195-203. 2005 Jan
10)Yu H. et al. Plasma levels of insulin-like growth factor-1, IGF-binding protein-3 and lung cancer risk: a case-control analysis. J. Natl. Cancer Inst. 91:151-6. 1999.
11)London SJ. Et al. Insulin-like growth factor-1, IGF-binding protein-3 and lung cancer risk in a prospective study of men in China. J. Natl. Cancer Inst. 94:749-54. 2002.
12)Lee HY. Et al. Insulin-like growth factor binding protein-3 inhibits the growth of non-small cell lung cancer. Cancer Res. 62:5530-7. 2002.
13) Liu C. et al. Lycopene supplementation inhibits lung squamous metaplasia and induces apoptosis via up-regulating insulin-like growth factor-binding protein-3 in cigarette smoke ferrets. Cancer Res. 63-3138-44. 2003.
14) Vrieling A. et al. Isolated isoflavones do not affect the circulation Insulin-like growth factor system in man at increased colorectal cancer risk. J. Nutr. 137 (2):379-83. 2007 Feb
15) Giovannucci E. et al. A prospective study of plasma Insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol Biomarkers and Prev. 9:345-9. 2000.
16)Giovannucci E Insulin-like growth factors and colon cancer: a review of the evidence. J. Nutr. 131:3109s-20s. 2001
17)Renchan AG. et al. Insulin-like growth factor (IGF)-1, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet. 363:1346-53. 1994.
18)Furstenberger G. et al. Serum levels of IGF-1 and IGFBP-3 during adjuvant chemotherapy for primary breast cancer. Breast 15(1):64-68, 2006 Feb.
19)Zhao H. et al. Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk. J. Urology 169(2):714-7, 2003 Feb.